Company / Operating Income
Neogen Operating Income History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$1.1B
FY2024
5-year range
-$1.1B / $58.7M
FY2020-FY2024
Trend
-1908.6%
vs FY2023
Sector context
#150 of 151
Health Care
What the data says
Operating Income changed -1909% YoY in FY2024, a notable deviation from the 8-year average annual change of -237%.
Based on SEC 10-K filings.
-$1.1B in FY2024.
Declined from $38M to -$1.1B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 151This company -$1.1B Sector average $716.7M
▼
-248.0% below sector average
Key checks
Key Insights
- In FY2024, operating income decreased 1908.6% year-over-year.
- Ranks #150 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$1.1B | -1908.6% |
| FY2023 | $58.7M | +56.4% |
| FY2022 | $37.5M | -36.0% |
| FY2021 | $58.6M | -21.0% |
| FY2020 | $74.2M | +9.8% |
| FY2019 | $67.5M | -0.8% |
| FY2018 | $68.1M | -3.0% |
| FY2017 | $70.2M | +8.1% |
| FY2016 | $64.9M | +15.2% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026